(MIST) – Hot FDA News
-
Milestone Pharmaceuticals Inc. (MIST) Receives Refusal to File Letter from FDA for NDA for Etripamil
-
Milestone Pharmaceuticals (MIST) Announces New Data from Phase 3 RAPID Trial of Etripamil Nasal Spray in Patients with PSVT During Late-Breaking Session at the AHA
-
Back to MIST Stock Lookup